Categories: Efficacy on Skin, Scalp, Nails, Teeth or MouthToxicology, safety, penetration, toleranceConsumer tests, Sensory AnalysisPreclinical assays (in-vitro, ex-vivo...)Clinical studies (in-vivo)RegulationOther services related to testingNon classé

Taiwan Clarifies the Scope of Cosmetic False, Exaggerated and Medical Efficacy Claims by Chemlinked

The scope of false, exaggerated and medical efficacy claims used for cosmetics in Taiwan is clarified.

On Jan. 10 and Jan. 19, 2019, TFDA released 2 cosmetic regulation drafts, “Particulars of Specific Purpose Cosmetics that May Be Voluntarily Modified” and “Regulations Governing of Criteria for the Label, Promotion and Advertisement of Cosmetic Products Identify False, Exaggerated or Medical Efficacy”. Cosmetic stakeholders with any suggestions or comments can send to us (cosmetic@chemlinked.com) before Mar 5, 2019. We will sort your suggestion, submit them to TFDA and send back the reply to you.

Regulations Governing Criteria for the Labeling, Promotion and Advertisement of Cosmetic Products Identified as Using False, Exaggerated or Medical Efficacy Claims

Cosmetic Hygiene Safety Administration Act released on May 2, 2018, stipulated that the labels, claims and advertisements of cosmetics shall not be false, exaggerated or indicate medical efficacy. The draft clarifies the scope of false, exaggerated or medical efficacy claims, as well as acceptable claims/labels/advertisements.